358 related articles for article (PubMed ID: 26123090)
21. Ultra-widefield imaging with autofluorescence and indocyanine green angiography in central serous chorioretinopathy.
Pang CE; Shah VP; Sarraf D; Freund KB
Am J Ophthalmol; 2014 Aug; 158(2):362-371.e2. PubMed ID: 24794091
[TBL] [Abstract][Full Text] [Related]
22. Clinical and immunological characterization of paraneoplastic retinopathy.
Makiyama Y; Kikuchi T; Otani A; Oishi A; Guo C; Nakagawa S; Ogino K; Kojima H; Kurimoto M; Yoshimura N
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5424-31. PubMed ID: 23860756
[TBL] [Abstract][Full Text] [Related]
23. Correlation between fundus autofluorescence and central visual function in chronic central serous chorioretinopathy.
Eandi CM; Piccolino FC; Alovisi C; Tridico F; Giacomello D; Grignolo FM
Am J Ophthalmol; 2015 Apr; 159(4):652-8. PubMed ID: 25555802
[TBL] [Abstract][Full Text] [Related]
24. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.
Jirarattanasopa P; Ooto S; Tsujikawa A; Yamashiro K; Hangai M; Hirata M; Matsumoto A; Yoshimura N
Ophthalmology; 2012 Aug; 119(8):1666-78. PubMed ID: 22521082
[TBL] [Abstract][Full Text] [Related]
25. Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome.
Yadav NK; Jayadev C; Mohan A; Vijayan P; Battu R; Dabir S; Shetty B; Shetty R;
Eye (Lond); 2015 Feb; 29(2):258-64; quiz 265. PubMed ID: 25613846
[TBL] [Abstract][Full Text] [Related]
26. Optical coherence tomographic assessment of diabetic macular edema: comparison with fluorescein angiographic and clinical findings.
Ozdek SC; Erdinç MA; Gürelik G; Aydin B; Bahçeci U; Hasanreisoğlu B
Ophthalmologica; 2005; 219(2):86-92. PubMed ID: 15802932
[TBL] [Abstract][Full Text] [Related]
27. Comparison of features on SD-OCT between acute central serous chorioretinopathy and exudative age-related macular degeneration.
Ahn SJ; Kim TW; Huh JW; Yu HG; Chung H
Ophthalmic Surg Lasers Imaging; 2012; 43(5):374-82. PubMed ID: 22767337
[TBL] [Abstract][Full Text] [Related]
28. Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study.
Bousquet E; Beydoun T; Zhao M; Hassan L; Offret O; Behar-Cohen F
Retina; 2013; 33(10):2096-102. PubMed ID: 23719402
[TBL] [Abstract][Full Text] [Related]
29. Retro-mode Imaging for retinal pigment epithelium alterations in central serous chorioretinopathy.
Shin YU; Lee BR
Am J Ophthalmol; 2012 Jul; 154(1):155-163.e4. PubMed ID: 22503695
[TBL] [Abstract][Full Text] [Related]
30. Fundus autofluorescence in acute and chronic central serous chorioretinopathy.
Dinc UA; Tatlipinar S; Yenerel M; Görgün E; Ciftci F
Clin Exp Optom; 2011 Sep; 94(5):452-7. PubMed ID: 21480989
[TBL] [Abstract][Full Text] [Related]
31. A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy.
Sayegh RG; Simader C; Scheschy U; Montuoro A; Kiss C; Sacu S; Kreil DP; Prünte C; Schmidt-Erfurth U
Ophthalmology; 2011 Sep; 118(9):1844-51. PubMed ID: 21496928
[TBL] [Abstract][Full Text] [Related]
32. Correlation between morphological characteristics in spectral-domain-optical coherence tomography, different functional tests and a patient's subjective handicap in acute central serous chorioretinopathy.
Gerendas BS; Kroisamer JS; Buehl W; Rezar-Dreindl SM; Eibenberger KM; Pablik E; Schmidt-Erfurth U; Sacu S
Acta Ophthalmol; 2018 Nov; 96(7):e776-e782. PubMed ID: 29338130
[TBL] [Abstract][Full Text] [Related]
33. [Ocular toxicity of targeted therapies with MEK inhibitors and BRAF inhibitors in the treatment of metastatic cutaneous melanoma].
Fauviaux E; Promelle V; Boucenna V; Jany B; Errera MH; Delbarre M; Boucenna W
J Fr Ophtalmol; 2022 Jun; 45(6):612-618. PubMed ID: 35501194
[TBL] [Abstract][Full Text] [Related]
34. Does microperimetry have a prognostic value in central serous chorioretinopathy?
Roisman L; Ribeiro JC; Fechine FV; Lavinsky D; Moraes N; Campos M; Farah ME
Retina; 2014 Apr; 34(4):713-8. PubMed ID: 23975001
[TBL] [Abstract][Full Text] [Related]
35. Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography.
Markomichelakis NN; Halkiadakis I; Pantelia E; Peponis V; Patelis A; Theodossiadis P; Theodossiadis G
Ophthalmology; 2004 May; 111(5):946-53. PubMed ID: 15121373
[TBL] [Abstract][Full Text] [Related]
36. Correlation of spectral domain optical coherence tomography findings and visual acuity in central serous chorioretinopathy.
Yalcinbayir O; Gelisken O; Akova-Budak B; Ozkaya G; Gorkem Cevik S; Yucel AA
Retina; 2014 Apr; 34(4):705-12. PubMed ID: 24100708
[TBL] [Abstract][Full Text] [Related]
37. Retinal pigment epithelial dysfunction in human immunodeficiency virus-infected patients with cytomegalovirus retinitis.
Harrison JM; van Heuven WA
Ophthalmology; 1999 Apr; 106(4):790-7. PubMed ID: 10201604
[TBL] [Abstract][Full Text] [Related]
38. Pachychoroid pigment epitheliopathy.
Warrow DJ; Hoang QV; Freund KB
Retina; 2013 Sep; 33(8):1659-72. PubMed ID: 23751942
[TBL] [Abstract][Full Text] [Related]
39. How to MEK the best of uveal melanoma: A systematic review on the efficacy and safety of MEK inhibitors in metastatic or unresectable uveal melanoma.
Steeb T; Wessely A; Ruzicka T; Heppt MV; Berking C
Eur J Cancer; 2018 Nov; 103():41-51. PubMed ID: 30205280
[TBL] [Abstract][Full Text] [Related]
40. [Multifocal serous chorioretinopathy secondary to the use of MEK inhibitors: Illustration and example of management through two case reports].
Coutu A; Farguette F; Jeannin G; Chiambaretta F
J Fr Ophtalmol; 2016 Jan; 39(1):55-63. PubMed ID: 26747016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
